MMC International Health Holding S.L entered into sale of shares agreement to acquire Farmalider, S.A. from Ascendis Health Limited (JSE:ASC) for €5 million on June 25, 2021. The consideration is paid in cash. The transaction is subject to Ascendis Health obtaining the written approval of Ascendis Health’s lenders under the existing bank facilities, of the sale and transfer of the Sale Shares contemplated by the SPA, to the extent required, the Financial Surveillance Department of the South African Reserve Bank approving the sale and transfer of the Sale Shares contemplated by the SPA and the finalisation of a licence and supply agreement between the Company and Farmalider, by no later than 2 July 2021. Ascendis Health will use the net proceeds from the Disposal to reduce the Group’s debt. The Disposal will be implemented on the Closing Date, which is expected to take place within 10 business days from the date of fulfilment of the Conditions Precedent . As of July 9, 2021, the transaction is now unconditional.